Pharmaceutically acceptable salts of 4'-(9-acridinylamino) methanesulfon-m-anisidide, their production, and pharmaceutical compositions containing such salts
申请人:WARNER-LAMBERT COMPANY
公开号:EP0035862A2
公开(公告)日:1981-09-16
For use as, inter alia, an anti-neoplastic agent, there is disclosed a compound of the formula:-
wherein X is an acid having a total of from three to six carbon atoms, two to five hydroxy groups and an acidic group selected from-CO2H and-OPO3H2 with the proviso that, when the total number of carbon atoms is three or four, the acidic group is -OP03H2. These particular salts of 4'-(9- acridinylamino)methanesulfon- m-anisidide remain in solution for a reasonable period and hence permit the use of the compound in this salt form for introduction into a mammal. Also disclosed are the processes for producing the salts and pharmaceutical compositions including the salts.
为用作抗肿瘤剂等,公开了一种式如下的化合物:- 其中 X 是具有三至六个碳原子、二至五个羟基和一个选自-CO2H 和-OPO3H2 的酸性基团的酸,但当碳原子总数为三或四个时,酸性基团为-OP03H2。 4'-(9-吖啶基氨基)甲磺酰-m-茴香酰胺的这些特定盐可在溶液中保持一段合理的时间,因此允许使用这种盐形式的化合物进入哺乳动物体内。 还公开了生产这些盐和包括这些盐的药物组合物的工艺。